Monitoring and personalization in treatment of breast cancer patients with metastatic bone lesions
Open Access
- 31 January 2022
- journal article
- Published by OU Scientific Route in EUREKA: Health Sciences
- No. 1,p. 37-48
- https://doi.org/10.21303/2504-5679.2022.002270
Abstract
The aim. To increase the efficiency of treatment of BC patients with metastatic lesions of long tubular bones by using, Multidetector computed tomography (MDCT) and bone marrow markers for diagnostics and monitoring the clinical course of the oncologic process, accompanied by surgical intervention with endoprosthetics along with the treatment of polymorbid pathology in a specific patient. Materials and methods. Authors provide systemic personification including visualization of the tumor site and its vascularization; printing out the 3D model; surgical planning, including optimal surgical access to the tumor site considering the volume and topographic and anatomical location and dissemination of the tumor, the convenience of intraoperative tasks (removal of the tumor, bone grafting or endoprosthetics), preoperative planning of bone resection lines with maximum preservation of intact bone tissue. Results. Personalization of the treatment of breast cancer patients with metastatic bone lesions contributes to a significant reduction in postoperative complications of endoprosthetic replacement of large joints (up to 15.2 %) and increases the overall three-year survival rate (up to 40.6 %), as well as significantly improves their quality of life. Conclusions. The personalization of treatment of patients with tumor lesions of the skeletons contributes to a significant decrease in the indicator of postoperative complications of endoprosthetics of great joints and to an increase in the total three-year survival rate, as well as to the improvement of the quality of life after the conducted treatment.Keywords
This publication has 35 references indexed in Scilit:
- Impact of symptomatic skeletal events on health-care resource utilization and quality of life among patients with castration-resistant prostate cancer and bone metastasesProstate Cancer and Prostatic Diseases, 2017
- Bone metastasis risk factors in breast cancerecancermedicalscience, 2017
- Characteristics and Significance of the Pre-metastatic NicheCancer Cell, 2016
- Treatment of pathological fractures of the long bonesEFORT Open Reviews, 2016
- The rejuvenated scenario of epithelial–mesenchymal transition (EMT) and cancer metastasisCancer and Metastasis Reviews, 2012
- Failure Mode Classification for Tumor Endoprostheses: Retrospective Review of Five Institutions and a Literature ReviewJournal of Bone and Joint Surgery, 2011
- Mechanisms of bone metastases of breast cancerEndocrine-Related Cancer, 2009
- Multidisciplinary Approach to the Treatment of Bone Metastases: Osteo-Oncology Center, a New Organizational ModelTumori Journal, 2009
- Metastatic bone disease: clinical features, pathophysiology and treatment strategiesCancer Treatment Reviews, 2001
- Development of clinical guidelinesThe Lancet, 1998